| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Simulation Training | 13 | 2020 | 139 | 4.630 |
Why?
|
| Specialties, Surgical | 8 | 2020 | 79 | 4.080 |
Why?
|
| Thoracoscopy | 13 | 2018 | 40 | 3.810 |
Why?
|
| Pediatrics | 13 | 2020 | 1139 | 3.180 |
Why?
|
| Models, Anatomic | 9 | 2014 | 98 | 3.170 |
Why?
|
| Laparoscopy | 13 | 2020 | 501 | 2.280 |
Why?
|
| Clinical Competence | 12 | 2020 | 978 | 2.020 |
Why?
|
| Education, Medical, Graduate | 6 | 2020 | 510 | 1.960 |
Why?
|
| Tracheoesophageal Fistula | 5 | 2016 | 48 | 1.550 |
Why?
|
| Esophageal Atresia | 4 | 2017 | 51 | 1.460 |
Why?
|
| Gastrostomy | 4 | 2018 | 84 | 0.980 |
Why?
|
| Education, Medical, Continuing | 2 | 2018 | 140 | 0.960 |
Why?
|
| Digestive System Surgical Procedures | 3 | 2014 | 84 | 0.870 |
Why?
|
| Torsion Abnormality | 2 | 2013 | 34 | 0.840 |
Why?
|
| Tissue Adhesions | 2 | 2014 | 29 | 0.830 |
Why?
|
| Intestinal Obstruction | 3 | 2014 | 97 | 0.820 |
Why?
|
| Computer Simulation | 2 | 2014 | 637 | 0.740 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2022 | 68 | 0.740 |
Why?
|
| Herniorrhaphy | 3 | 2020 | 80 | 0.710 |
Why?
|
| Hernia, Diaphragmatic | 4 | 2016 | 97 | 0.700 |
Why?
|
| Intestine, Small | 2 | 2014 | 302 | 0.700 |
Why?
|
| Competency-Based Education | 2 | 2020 | 70 | 0.690 |
Why?
|
| Common Bile Duct | 2 | 2016 | 14 | 0.680 |
Why?
|
| Printing, Three-Dimensional | 3 | 2014 | 69 | 0.650 |
Why?
|
| Psychomotor Performance | 1 | 2020 | 188 | 0.640 |
Why?
|
| General Surgery | 3 | 2017 | 203 | 0.630 |
Why?
|
| Duodenal Obstruction | 2 | 2016 | 14 | 0.620 |
Why?
|
| Postoperative Complications | 6 | 2018 | 3007 | 0.620 |
Why?
|
| Fundoplication | 2 | 2009 | 66 | 0.590 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 401 | 0.580 |
Why?
|
| Abnormalities, Multiple | 2 | 2013 | 965 | 0.550 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2016 | 193 | 0.550 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 4 | 2016 | 383 | 0.520 |
Why?
|
| Bronchi | 1 | 2016 | 100 | 0.510 |
Why?
|
| Documentation | 1 | 2016 | 115 | 0.510 |
Why?
|
| Catheterization, Peripheral | 1 | 2017 | 126 | 0.510 |
Why?
|
| Humans | 56 | 2022 | 123190 | 0.460 |
Why?
|
| Macrophages, Peritoneal | 2 | 2004 | 38 | 0.460 |
Why?
|
| Infant | 18 | 2020 | 12323 | 0.460 |
Why?
|
| Cost Control | 1 | 2014 | 24 | 0.460 |
Why?
|
| Connective Tissue | 1 | 2014 | 21 | 0.450 |
Why?
|
| Retrospective Studies | 18 | 2022 | 15979 | 0.450 |
Why?
|
| Wounds, Nonpenetrating | 3 | 2004 | 205 | 0.450 |
Why?
|
| Pneumonectomy | 1 | 2014 | 127 | 0.440 |
Why?
|
| Prune Belly Syndrome | 1 | 2013 | 4 | 0.430 |
Why?
|
| Ovarian Diseases | 1 | 2013 | 28 | 0.430 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2013 | 57 | 0.430 |
Why?
|
| Umbilicus | 1 | 2013 | 13 | 0.430 |
Why?
|
| Teaching | 1 | 2014 | 182 | 0.420 |
Why?
|
| Models, Educational | 1 | 2013 | 69 | 0.420 |
Why?
|
| Splenic Diseases | 1 | 2013 | 28 | 0.420 |
Why?
|
| Infant, Newborn | 14 | 2018 | 8089 | 0.420 |
Why?
|
| Quality Improvement | 3 | 2020 | 624 | 0.420 |
Why?
|
| Arteriovenous Malformations | 1 | 2013 | 46 | 0.410 |
Why?
|
| Intestinal Volvulus | 1 | 2013 | 36 | 0.410 |
Why?
|
| Enteral Nutrition | 2 | 2014 | 250 | 0.410 |
Why?
|
| Internship and Residency | 4 | 2017 | 1158 | 0.400 |
Why?
|
| Rare Diseases | 1 | 2014 | 185 | 0.390 |
Why?
|
| Appendectomy | 1 | 2012 | 88 | 0.390 |
Why?
|
| Skin Diseases, Infectious | 1 | 2011 | 24 | 0.380 |
Why?
|
| Hemorrhage | 2 | 2005 | 459 | 0.380 |
Why?
|
| Congenital Abnormalities | 1 | 2014 | 246 | 0.370 |
Why?
|
| Appendicitis | 1 | 2012 | 128 | 0.360 |
Why?
|
| Soft Tissue Infections | 1 | 2011 | 83 | 0.360 |
Why?
|
| Curriculum | 2 | 2017 | 722 | 0.360 |
Why?
|
| Intestinal Atresia | 3 | 2016 | 19 | 0.340 |
Why?
|
| Child | 18 | 2022 | 24208 | 0.340 |
Why?
|
| Attitude of Health Personnel | 4 | 2016 | 640 | 0.340 |
Why?
|
| Ribs | 3 | 2014 | 44 | 0.340 |
Why?
|
| Cattle | 3 | 2014 | 559 | 0.320 |
Why?
|
| Child, Preschool | 14 | 2020 | 13862 | 0.320 |
Why?
|
| Equipment Design | 4 | 2014 | 600 | 0.310 |
Why?
|
| Trauma Centers | 3 | 2004 | 171 | 0.310 |
Why?
|
| United States | 9 | 2020 | 10618 | 0.310 |
Why?
|
| Adolescent | 14 | 2018 | 19086 | 0.300 |
Why?
|
| Receptors, Cell Surface | 3 | 2004 | 469 | 0.280 |
Why?
|
| Membrane Glycoproteins | 3 | 2004 | 414 | 0.280 |
Why?
|
| Interleukin-10 | 2 | 2004 | 170 | 0.260 |
Why?
|
| Sternum | 1 | 2005 | 53 | 0.250 |
Why?
|
| Lung Diseases | 2 | 2012 | 385 | 0.250 |
Why?
|
| Renal Veins | 1 | 2004 | 35 | 0.240 |
Why?
|
| Gastroesophageal Reflux | 1 | 2007 | 289 | 0.230 |
Why?
|
| Prostheses and Implants | 1 | 2005 | 151 | 0.230 |
Why?
|
| Computer-Aided Design | 2 | 2014 | 21 | 0.230 |
Why?
|
| Renal Artery | 1 | 2004 | 73 | 0.230 |
Why?
|
| Interleukin-1 | 1 | 2004 | 141 | 0.220 |
Why?
|
| Rib Fractures | 1 | 2003 | 21 | 0.220 |
Why?
|
| Educational Measurement | 3 | 2017 | 326 | 0.220 |
Why?
|
| Surveys and Questionnaires | 4 | 2020 | 3662 | 0.220 |
Why?
|
| Nephrectomy | 1 | 2004 | 172 | 0.210 |
Why?
|
| Hospitalization | 1 | 2011 | 1733 | 0.210 |
Why?
|
| Diaphragm | 1 | 2004 | 97 | 0.210 |
Why?
|
| Male | 24 | 2020 | 60020 | 0.210 |
Why?
|
| Mammary Arteries | 2 | 2017 | 26 | 0.210 |
Why?
|
| Inflammation Mediators | 1 | 2004 | 234 | 0.210 |
Why?
|
| Funnel Chest | 2 | 2017 | 34 | 0.200 |
Why?
|
| Foreign Bodies | 2 | 2016 | 104 | 0.190 |
Why?
|
| Female | 19 | 2020 | 65427 | 0.190 |
Why?
|
| Patient Selection | 1 | 2004 | 685 | 0.180 |
Why?
|
| Biomedical Research | 2 | 2016 | 519 | 0.180 |
Why?
|
| Child Abuse | 1 | 2003 | 195 | 0.180 |
Why?
|
| Hernia, Inguinal | 1 | 2020 | 41 | 0.180 |
Why?
|
| Formative Feedback | 1 | 2020 | 31 | 0.170 |
Why?
|
| Pain Management | 1 | 2022 | 174 | 0.170 |
Why?
|
| Colorado | 3 | 2004 | 22 | 0.170 |
Why?
|
| Consumer Behavior | 1 | 2020 | 38 | 0.170 |
Why?
|
| Circumcision, Male | 1 | 2020 | 25 | 0.170 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 587 | 0.160 |
Why?
|
| Video Recording | 1 | 2020 | 181 | 0.160 |
Why?
|
| Secondary Prevention | 1 | 2020 | 211 | 0.160 |
Why?
|
| Elective Surgical Procedures | 1 | 2020 | 161 | 0.160 |
Why?
|
| Bandages, Hydrocolloid | 1 | 2018 | 2 | 0.160 |
Why?
|
| Pain, Postoperative | 1 | 2022 | 255 | 0.160 |
Why?
|
| Granulation Tissue | 1 | 2018 | 12 | 0.160 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2018 | 52 | 0.150 |
Why?
|
| Radiography | 3 | 2013 | 818 | 0.150 |
Why?
|
| Chicago | 1 | 2018 | 21 | 0.150 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2004 | 670 | 0.150 |
Why?
|
| Bone Nails | 1 | 2017 | 21 | 0.150 |
Why?
|
| Thoracoplasty | 1 | 2017 | 3 | 0.150 |
Why?
|
| Arterio-Arterial Fistula | 1 | 2017 | 8 | 0.150 |
Why?
|
| Humeral Fractures | 1 | 2017 | 22 | 0.140 |
Why?
|
| Fracture Fixation, Internal | 1 | 2017 | 72 | 0.140 |
Why?
|
| Kidney | 1 | 2004 | 1338 | 0.140 |
Why?
|
| Incidence | 3 | 2011 | 3050 | 0.140 |
Why?
|
| Orthopedics | 1 | 2017 | 66 | 0.140 |
Why?
|
| Age Distribution | 2 | 2011 | 410 | 0.140 |
Why?
|
| Ambulatory Care | 1 | 2020 | 376 | 0.140 |
Why?
|
| Plague | 1 | 2016 | 3 | 0.140 |
Why?
|
| Learning | 1 | 2020 | 361 | 0.140 |
Why?
|
| Choledocholithiasis | 1 | 2016 | 15 | 0.140 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 2851 | 0.140 |
Why?
|
| Bronchoscopy | 1 | 2017 | 157 | 0.130 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2022 | 711 | 0.130 |
Why?
|
| Animals | 8 | 2014 | 33740 | 0.130 |
Why?
|
| Insurance Coverage | 2 | 2020 | 121 | 0.130 |
Why?
|
| Risk Factors | 5 | 2017 | 10001 | 0.130 |
Why?
|
| Length of Stay | 3 | 2011 | 1284 | 0.130 |
Why?
|
| Treatment Outcome | 8 | 2016 | 12102 | 0.120 |
Why?
|
| Self Efficacy | 1 | 2016 | 193 | 0.120 |
Why?
|
| Lung | 3 | 2012 | 1469 | 0.120 |
Why?
|
| Reoperation | 2 | 2009 | 819 | 0.120 |
Why?
|
| Silicones | 1 | 2014 | 33 | 0.120 |
Why?
|
| Educational Technology | 1 | 2014 | 7 | 0.120 |
Why?
|
| Wound Healing | 1 | 2018 | 452 | 0.120 |
Why?
|
| Birth Weight | 1 | 2016 | 336 | 0.120 |
Why?
|
| Caregivers | 1 | 2020 | 564 | 0.120 |
Why?
|
| Trachea | 2 | 2014 | 202 | 0.120 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 1069 | 0.110 |
Why?
|
| Time and Motion Studies | 1 | 2013 | 21 | 0.110 |
Why?
|
| Pulmonary Artery | 1 | 2017 | 439 | 0.110 |
Why?
|
| Videotape Recording | 1 | 2013 | 57 | 0.110 |
Why?
|
| Diagnostic Imaging | 1 | 2016 | 272 | 0.110 |
Why?
|
| Castleman Disease | 1 | 2013 | 13 | 0.110 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 2108 | 0.110 |
Why?
|
| Mesentery | 1 | 2013 | 28 | 0.110 |
Why?
|
| Injury Severity Score | 2 | 2004 | 219 | 0.110 |
Why?
|
| False Negative Reactions | 1 | 2013 | 90 | 0.110 |
Why?
|
| Recurrence | 3 | 2020 | 1420 | 0.110 |
Why?
|
| Anastomosis, Surgical | 1 | 2013 | 169 | 0.110 |
Why?
|
| Lipopolysaccharides | 3 | 2004 | 291 | 0.110 |
Why?
|
| False Positive Reactions | 1 | 2013 | 145 | 0.110 |
Why?
|
| Esophagus | 1 | 2014 | 213 | 0.110 |
Why?
|
| Hospitals, Pediatric | 2 | 2010 | 780 | 0.100 |
Why?
|
| Models, Animal | 1 | 2014 | 465 | 0.100 |
Why?
|
| Interdisciplinary Communication | 1 | 2013 | 134 | 0.100 |
Why?
|
| Comorbidity | 2 | 2010 | 1498 | 0.100 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 219 | 0.100 |
Why?
|
| Manikins | 1 | 2013 | 134 | 0.100 |
Why?
|
| Illinois | 1 | 2010 | 15 | 0.090 |
Why?
|
| Jejunal Diseases | 1 | 2010 | 14 | 0.090 |
Why?
|
| Superior Mesenteric Artery Syndrome | 1 | 2010 | 4 | 0.090 |
Why?
|
| Pyloric Stenosis, Hypertrophic | 1 | 2010 | 6 | 0.090 |
Why?
|
| Hospitals, General | 1 | 2010 | 24 | 0.090 |
Why?
|
| Duodenal Diseases | 1 | 2010 | 34 | 0.090 |
Why?
|
| Hospital Costs | 1 | 2011 | 178 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 359 | 0.090 |
Why?
|
| Surgical Procedures, Operative | 2 | 2002 | 182 | 0.090 |
Why?
|
| Self Report | 1 | 2013 | 514 | 0.090 |
Why?
|
| Immunocompromised Host | 1 | 2012 | 300 | 0.090 |
Why?
|
| Drainage | 1 | 2011 | 254 | 0.090 |
Why?
|
| Electronic Health Records | 1 | 2016 | 698 | 0.080 |
Why?
|
| Databases, Factual | 2 | 2011 | 1169 | 0.080 |
Why?
|
| Spinal Fusion | 1 | 2010 | 107 | 0.080 |
Why?
|
| Toll-Like Receptors | 3 | 2004 | 84 | 0.080 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2011 | 220 | 0.080 |
Why?
|
| Scoliosis | 1 | 2010 | 134 | 0.080 |
Why?
|
| Abdomen | 1 | 2009 | 130 | 0.080 |
Why?
|
| Patient Discharge | 1 | 2011 | 488 | 0.070 |
Why?
|
| Mice, Inbred C3H | 2 | 2004 | 118 | 0.070 |
Why?
|
| Laparotomy | 1 | 2007 | 135 | 0.070 |
Why?
|
| Staphylococcal Infections | 1 | 2011 | 553 | 0.070 |
Why?
|
| Drosophila Proteins | 2 | 2002 | 707 | 0.070 |
Why?
|
| Logistic Models | 1 | 2011 | 1799 | 0.070 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2004 | 143 | 0.060 |
Why?
|
| Middle Aged | 3 | 2016 | 25976 | 0.060 |
Why?
|
| Foreign-Body Migration | 1 | 2005 | 74 | 0.060 |
Why?
|
| Interleukin-6 | 2 | 2004 | 393 | 0.060 |
Why?
|
| Gastrointestinal Diseases | 1 | 2008 | 335 | 0.060 |
Why?
|
| Hypertension, Renovascular | 1 | 2004 | 29 | 0.060 |
Why?
|
| NF-kappa B | 2 | 2004 | 459 | 0.060 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2005 | 92 | 0.060 |
Why?
|
| Rupture | 1 | 2004 | 32 | 0.060 |
Why?
|
| Neutrophil Infiltration | 1 | 2004 | 65 | 0.060 |
Why?
|
| Permeability | 1 | 2004 | 118 | 0.060 |
Why?
|
| Safety | 1 | 2004 | 217 | 0.060 |
Why?
|
| Morbidity | 1 | 2004 | 240 | 0.050 |
Why?
|
| Endotoxemia | 1 | 2004 | 56 | 0.050 |
Why?
|
| Multiple Trauma | 1 | 2004 | 63 | 0.050 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 2002 | 10 | 0.050 |
Why?
|
| Interleukin-11 | 1 | 2002 | 7 | 0.050 |
Why?
|
| Creatinine | 1 | 2004 | 380 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2004 | 1011 | 0.050 |
Why?
|
| Renal Insufficiency | 1 | 2004 | 233 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2004 | 3050 | 0.050 |
Why?
|
| Acute Disease | 1 | 2004 | 1090 | 0.050 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2002 | 239 | 0.050 |
Why?
|
| Peritoneum | 1 | 2020 | 36 | 0.040 |
Why?
|
| Cardiovascular System | 1 | 2001 | 100 | 0.040 |
Why?
|
| Dissection | 1 | 2020 | 52 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2001 | 240 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 1 | 2001 | 211 | 0.040 |
Why?
|
| Neutrophils | 1 | 2002 | 372 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2002 | 264 | 0.040 |
Why?
|
| Operative Time | 1 | 2020 | 160 | 0.040 |
Why?
|
| Blood Loss, Surgical | 1 | 2020 | 146 | 0.040 |
Why?
|
| Gestational Age | 2 | 2016 | 1121 | 0.040 |
Why?
|
| Observer Variation | 1 | 2020 | 302 | 0.040 |
Why?
|
| Time Factors | 2 | 2008 | 6201 | 0.040 |
Why?
|
| Suture Techniques | 1 | 2020 | 199 | 0.040 |
Why?
|
| Aged | 1 | 2016 | 19068 | 0.040 |
Why?
|
| Time-to-Treatment | 1 | 2020 | 186 | 0.040 |
Why?
|
| Attitude to Health | 1 | 2020 | 260 | 0.040 |
Why?
|
| Registries | 1 | 2004 | 1390 | 0.040 |
Why?
|
| Adult | 3 | 2017 | 29035 | 0.040 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2017 | 51 | 0.040 |
Why?
|
| Age Factors | 1 | 2004 | 2801 | 0.040 |
Why?
|
| Renal Dialysis | 1 | 2004 | 842 | 0.040 |
Why?
|
| Young Adult | 1 | 2011 | 8868 | 0.030 |
Why?
|
| High-Frequency Ventilation | 1 | 2016 | 16 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 2043 | 0.030 |
Why?
|
| Cytokines | 1 | 2002 | 1284 | 0.030 |
Why?
|
| Preventive Medicine | 1 | 2016 | 22 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1387 | 0.030 |
Why?
|
| Professional Practice | 1 | 2016 | 42 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 2016 | 137 | 0.030 |
Why?
|
| Research Support as Topic | 1 | 2016 | 64 | 0.030 |
Why?
|
| Radiation Protection | 1 | 2016 | 54 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2016 | 132 | 0.030 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2017 | 169 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2004 | 2533 | 0.030 |
Why?
|
| Diffusion of Innovation | 1 | 2016 | 97 | 0.030 |
Why?
|
| Embolization, Therapeutic | 1 | 2017 | 226 | 0.030 |
Why?
|
| Capsule Endoscopy | 1 | 2013 | 20 | 0.030 |
Why?
|
| Peritoneal Neoplasms | 1 | 2013 | 28 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2016 | 313 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2013 | 90 | 0.030 |
Why?
|
| Least-Squares Analysis | 1 | 2010 | 30 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2002 | 815 | 0.020 |
Why?
|
| Hospital Charges | 1 | 2010 | 61 | 0.020 |
Why?
|
| Mice | 2 | 2004 | 17497 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2002 | 4508 | 0.020 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2016 | 628 | 0.020 |
Why?
|
| Anemia | 1 | 2013 | 339 | 0.020 |
Why?
|
| Biopsy | 1 | 2012 | 1239 | 0.020 |
Why?
|
| Polytetrafluoroethylene | 1 | 2008 | 80 | 0.020 |
Why?
|
| Surgical Mesh | 1 | 2008 | 62 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 1871 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2018 | 6028 | 0.020 |
Why?
|
| Inpatients | 1 | 2010 | 492 | 0.020 |
Why?
|
| Collateral Circulation | 1 | 2002 | 45 | 0.010 |
Why?
|
| Monokines | 1 | 2002 | 2 | 0.010 |
Why?
|
| Chemokine CXCL2 | 1 | 2002 | 5 | 0.010 |
Why?
|
| Mitochondria, Heart | 1 | 2002 | 60 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2002 | 54 | 0.010 |
Why?
|
| Transcription Factor RelA | 1 | 2002 | 53 | 0.010 |
Why?
|
| Peroxidase | 1 | 2002 | 61 | 0.010 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2002 | 61 | 0.010 |
Why?
|
| Receptors, Cytokine | 1 | 2002 | 58 | 0.010 |
Why?
|
| Cell Count | 1 | 2002 | 248 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2002 | 159 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2001 | 49 | 0.010 |
Why?
|
| Endothelial Growth Factors | 1 | 2001 | 49 | 0.010 |
Why?
|
| Lymphokines | 1 | 2001 | 66 | 0.010 |
Why?
|
| Chemokines | 1 | 2002 | 138 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 2002 | 132 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 2002 | 208 | 0.010 |
Why?
|
| Interleukins | 1 | 2002 | 116 | 0.010 |
Why?
|
| Protein Transport | 1 | 2002 | 370 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 779 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 2002 | 332 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2002 | 402 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2002 | 374 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 5047 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2001 | 414 | 0.010 |
Why?
|
| Aorta | 1 | 2002 | 541 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2002 | 582 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 1684 | 0.010 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2002 | 314 | 0.010 |
Why?
|
| Homeostasis | 1 | 2002 | 681 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2001 | 1088 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 2024 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2002 | 980 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2001 | 744 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2002 | 1102 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2002 | 3332 | 0.010 |
Why?
|
| Neoplasms | 1 | 2002 | 2767 | 0.000 |
Why?
|